We help contrarian founders build generational biotech companies
Our expertise is at earliest stage possible. Launched from The Longevity Fund, we’ve backed some of the first longevity biotech companies to IPO and achieve clinical translation. We value pragmatism, rigor, and optimism.
OUR TEAM
Alex Colville
Co-Founder, General Partner
Laura Deming
Co-Founder, Venture Partner
Lily Clayton
Head of Operations
Kat Kajderowicz
Principal
Alex Kesin
Analyst
Carol Magalhaes
Venture Fellow
Maggie Li
Venture Fellow
Nathan Ramrakhiani
Venture Fellow
Satvik Dasariraju
Venture Fellow
Mihir Rao
Venture Intern